CAS 109351-34-0: (R)-Terazosin

Description: (R)-Terazosin is a pharmaceutical compound primarily used as an antihypertensive and an alpha-1 adrenergic antagonist. It is characterized by its chiral nature, with the (R) configuration indicating the specific spatial arrangement of its atoms. The molecular formula of (R)-Terazosin is C19H22N4O4S, and it features a sulfonamide group, which contributes to its pharmacological activity. This compound is typically administered in the form of its hydrochloride salt, enhancing its solubility and bioavailability. (R)-Terazosin works by relaxing blood vessels, thereby lowering blood pressure, and is also effective in treating benign prostatic hyperplasia by alleviating urinary symptoms. Its mechanism of action involves selective inhibition of alpha-1 adrenergic receptors, leading to smooth muscle relaxation. The substance is generally well-tolerated, though it may cause side effects such as dizziness or orthostatic hypotension. As with any medication, it is essential to use (R)-Terazosin under medical supervision to ensure safety and efficacy.

Synonyms:

• Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, (R)-
• Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[[(2R)-tetrahydro-2-furanyl]carbonyl]- (9CI)

(R)-Terazosin

CAS: 109351-34-0

R-Terazosin is the active R-enantiomer and potent α1-adrenoceptor antagonist (Ki: α1a 6.51 nM, α1b 1.01 …

• Formula: C₁₉H₂₅N₅O₄
• Purity: 98.87% - 98.96%
• Color and Shape: Solid
• Molecular weight: 387.43

(R)-Terazosin

CAS: 109351-34-0

• Formula: C₁₉H₂₅N₅O₄
• Color and Shape: Neat
• Molecular weight: 387.43

(R)-Terazosin

CAS: 109351-34-0

Terazosin is an alpha-adrenergic receptor antagonist that is used to treat benign prostatic hyperplasia, prostate …

• Formula: C₁₉H₂₅N₅O₄
• Purity: Min. 95%
• Molecular weight: 387.4 g/mol